These findings suggest RA-ILD sex differences may be driven by RA-UIP and emphasizes the importance of further studies to clarify RA-ILD heterogeneity and optimize screening and treatment approaches.

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD ...

My name is Madhu Agarwal and I am raising funds for my medical expenses. I am suffering from Interstitial lung disease (ILD) and am undergoing treatment at KIMS, Secunderabad. We have done all we can ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening ...

Interstitial Lung Diseases Pipeline Outlook DWN12088 is an investigational therapy for idiopathic ... A deuterated form of ...

we can eventually develop genetic interventional approaches to treatment. Diffuse interstitial lung disease causes major morbidity and mortality due to lung injury and fibrosis. If we can identify ...

Most new recommendations are related to skin fibrosis and ILD. These included novel recommendations for the use of mycophenolate mofetil, nintedanib, rituximab and tocilizumab for the treatment of ...

Interstitial lung disease (ILD), a condition characterized by inflammation and fibrosis, is a major cause of severe respiratory illness ... In a head-to-head study, FAPI PET/CT was found to be ...

"If you look at ILD and PE outcomes ... whereas a PE in fibrotic tissue may be clinically insignificant and not require treatment. "So it goes both ways: You don't overtreat and you don't ...